|
|
|
|
|
Welcome to Mathys Matters - your monthly update from Mathys & Squire, covering all the recent intellectual property and sector news/updates throughout May!
This month we’re shining a spotlight on the increase in the number of drone patents filed worldwide.
Our latest articles throughout May include: commentary on the European Patent Office (EPO) decision T 293/19, promotion news at Mathys & Squire, including three new partners, a discussion outlining factors to consider when drafting patent applications protecting materials used in medical devices, and an update on the Unified Patent Court (UPC) test case Mathys & Squire filed in support of open justice.
Scroll down to read more! |
|
|
|
|
|
|
SPOTLIGHT OF THE MONTH
- Number of drone patents filed worldwide jumps 16% in past year - |
|
|
The number of global patents filed for drone technology has increased 16% from 16,800 in 2022 to 19,700 in 2023 (includes patents for drone countermeasures), new research from Mathys & Squire shows. |
|
Increased innovation in drone technologies has been driven by greater research and development (R&D) spending in the defence sector, the ongoing integration of artificial intelligence (AI) into drone technology as well as drones that can better handle countermeasures. This reflects the growing usage of drones in military conflicts. |
|
Commentary by Partner Andrew White has been featured in The Independent and The Patent Lawyer, discussing how R&D in defence, alongside agriculture and logistics, is driving innovation in drone technology.
Click here to read more |
|
|
|
|
|
|
Does an inventive process entitle you to a claim to an obvious product? 30 May 2024
In recent EPO decision T 293/19, a Technical Board of Appeal has suggested that claims to products that could be envisaged as obvious improvements over the prior art, but which could not be produced using methods known in the art, may not be deemed inventive. This decision departs from a long-standing line of previous case law. In this article, Managing Associate Alex Elder and Partner Alexander Robinson discuss the decision and the significant departure it seems to represent from the principles established by T 595/90.
Read the article here |
|
| Mathys & Squire promotes three experts to partners 29 May 2024
Mathys & Squire is pleased to announce the promotion of Laura Clews, Samantha Moodie and Edd Cavanna to Partners at the firm. After joining Mathys & Squire as Technical Assistants, all three have grown into highly regarded specialists in their respective fields. Additionally, Mathys & Squire has promoted five attorneys to Managing Associates – Alex Elder, Adam Gilbertson, Lionel Newton, Oliver Parish and Leonard Wright. We are proud to have them at our firm and look forward to continue growing our practice and the exceptional services we deliver to our clients.
Read the article here |
|
|
|
Patenting materials in medical devices at the EPO 9 May 2024
Within the innovation-driven medical device industry, new materials can significantly enhance device performance, patient safety, and treatment outcomes, leading to competitive advantages. Protecting materials-related inventions is therefore of high importance. In this article, Managing Associate Chloe Flower discusses factors to consider when drafting patent applications protecting materials used in medical devices and highlights challenges that may arise.
Read the article here |
|
| Update on Mathys & Squire test case in support of open justice 8 May 2024
Mathys & Squire filed a test case to secure public access to evidence in the UPC at the end of November 2023. That case was stayed, pending the UPC Court of Appeal’s decision in Ocado v Autostore. The test case has now resumed and Partners Nicholas Fox, Alexander Robinson and Andreas Wietzke, acting on behalf of Mathys & Squire, have provided their comments to the Munich Central Division so that the Judge-Rapporteur can rule on their request.
Read the article here |
|
|
|
|
|
|
|
|
Mathys & Squire T: +44 (0)20 7830 0000 E: info@mathys-squire.com
@Mathys_Squire www.mathys-squire.com
If you no longer wish to receive emails from us, click here to unsubscribe. |
|
